These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7699424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 5. Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():43-7. PubMed ID: 3144548
    [Abstract] [Full Text] [Related]

  • 6. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G, Gaudio F, Ducroix JP, Orfila J.
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R, Jiménez Arriero M, Rodriguez-Tudela JL, Soriano F.
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
    Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    Chemotherapy; 1988 Dec; 34(3):191-4. PubMed ID: 2843324
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY, Chang SC, Luh KT, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991 Aug; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 15. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
    Aguilar L, Martín M, Balcabao IP, Gómez-Lus ML, Dal-Ré R, Prieto J.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
    [Abstract] [Full Text] [Related]

  • 16. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE, Slocombe B, White AR.
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract] [Full Text] [Related]

  • 17. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
    Cunha BA.
    Clin Ther; 1992 Jul; 14(3):418-25. PubMed ID: 1638583
    [Abstract] [Full Text] [Related]

  • 18. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J, Escoubas J, Fouche J, Mormede M.
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [Abstract] [Full Text] [Related]

  • 19. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
    Yeo SF, Livermore DM.
    J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.